F.D.A. Clears New Cancer-Fighting Drug From Roche

.

F.D.A. Clears New Cancer-Fighting Drug From Roche

A new drug from the drug company Roche has been given the nod by the US Food and Drug Administration (FDA) to improve the treatment of patients suffering from a kind of cancer of the blood and bone marrow.

Roche is calling the new medicine Gazyva which is meant to fight chronic lymphocytic leukemia along with added treatment with chemotherapy. It is meant for those patients who have never before been treated for the same.

Gazyva provides relief in this cancer by destroying cancer cells and enabling the natural immune system of the body to fight against them.

The FDA gave its approval to Gazyva after proof that the drug along with chemotherapy was a better treatment to chemotherapy alone in slowing the progress of the cancer cells.

It was also seen that cancer patients who got treatment from Gazyva combined with chemotherapy had a higher survival rate with 23 months before death, relapse or spreading of the cancer cells.

Earlier treatments treated only with chemotherapy only got 11.1 months.

The new drug Gazyva will be sold by Roche s Genentech unit.


Latest News

NHTSA opens probe into automatic braking system on 2014 GM Chevrolet Impala
Withings launches latest-generation Pulse fitness tracker --- Pulse O2
Google unveils new mobile ads which help find apps that fit users’ daily habits
Several Canadians experienced child abuse
12 per cent decrease in serious violence
Exercise plus sex burns more calories
Analysts discover mitochondria that are unable to repair itself
Microsoft's ‘Cortana’ virtual assistant for Windows Phone 8.1 OS
Twitter's new profile design is now available to all users
Kidney deaths at hospitals can be avoided
Movement makes some people feel sick
ADHD kids suffer language problems